IL6 and COVID-19: Due to the attenuated immune response of COVID-19 patients, particularly the reduced upregulation of monocyte CD80 expression and the suppressed release of key cytokines such as IL-6, TNF, IL-1a, and IL-1b, this may lead to a decreased ability to clear C. albicans in these patients [30].